GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (NYSE:DGX) » Definitions » Shiller PE Ratio

Quest Diagnostics (Quest Diagnostics) Shiller PE Ratio

: 15.38 (As of Today)
View and export this data going back to 1996. Start your Free Trial

As of today (2024-04-19), Quest Diagnostics's current share price is $128.44. Quest Diagnostics's E10 for the quarter that ended in Dec. 2023 was $8.35. Quest Diagnostics's Shiller PE Ratio for today is 15.38.

The historical rank and industry rank for Quest Diagnostics's Shiller PE Ratio or its related term are showing as below:

DGX' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.43   Med: 19.8   Max: 26.88
Current: 15.38

During the past years, Quest Diagnostics's highest Shiller PE Ratio was 26.88. The lowest was 14.43. And the median was 19.80.

DGX's Shiller PE Ratio is ranked better than
75.64% of 78 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.42 vs DGX: 15.38

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Quest Diagnostics's adjusted earnings per share data for the three months ended in Dec. 2023 was $1.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $8.35 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Quest Diagnostics Shiller PE Ratio Historical Data

The historical data trend for Quest Diagnostics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.46 21.26 23.92 19.42 16.52

Quest Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.42 17.13 16.70 14.62 16.52

Competitive Comparison

For the Diagnostics & Research subindustry, Quest Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics Shiller PE Ratio Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Shiller PE Ratio falls into.



Quest Diagnostics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Quest Diagnostics's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=128.44/8.35
=15.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Quest Diagnostics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.7/129.4194*129.4194
=1.700

Current CPI (Dec. 2023) = 129.4194.

Quest Diagnostics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.710 99.695 0.922
201406 0.920 100.560 1.184
201409 0.880 100.428 1.134
201412 1.290 99.070 1.685
201503 0.420 99.621 0.546
201506 0.810 100.684 1.041
201509 2.350 100.392 3.029
201512 1.290 99.792 1.673
201603 0.710 100.470 0.915
201606 1.370 101.688 1.744
201609 1.340 101.861 1.703
201612 1.090 101.863 1.385
201703 1.160 102.862 1.459
201706 1.370 103.349 1.716
201709 1.150 104.136 1.429
201712 1.820 104.011 2.265
201803 1.270 105.290 1.561
201806 1.570 106.317 1.911
201809 1.530 106.507 1.859
201812 0.920 105.998 1.123
201903 1.200 107.251 1.448
201906 1.660 108.070 1.988
201909 1.560 108.329 1.864
201912 1.860 108.420 2.220
202003 0.730 108.902 0.868
202006 1.360 108.767 1.618
202009 4.140 109.815 4.879
202012 4.210 109.897 4.958
202103 3.460 111.754 4.007
202106 4.960 114.631 5.600
202109 4.020 115.734 4.495
202112 3.120 117.630 3.433
202203 2.920 121.301 3.115
202206 1.960 125.017 2.029
202209 2.170 125.227 2.243
202212 0.870 125.222 0.899
202303 1.780 127.348 1.809
202306 2.050 128.729 2.061
202309 1.960 129.860 1.953
202312 1.700 129.419 1.700

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quest Diagnostics  (NYSE:DGX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Quest Diagnostics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (Quest Diagnostics) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Executives
Luis Diaz director C/O JOUNCE THERAPEUTICS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02138
Michael E Prevoznik officer: Corp VP, Legal & Compliance C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Catherine T. Doherty officer: SVP, Physician Services Bus. C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Timothy M Ring director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
Mark E Delaney officer: SVP & Chief Commercial Officer 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Mark A Gardner officer: SVP of Molecular Gen & Oncol 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Patrick Plewman officer: SVP for Diagnostic Services 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Karthik Kuppusamy officer: SVP, Clinical Solutions 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS NJ 07094
Michael J Deppe officer: VP, Corp. Controller & CAO 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS, SECAUCUS NJ 07094
Samer Abdul Samad officer: Executive Vice President & CFO 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Stephen H Rusckowski director, officer: President and CEO C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Tracey Doi director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Gail R Wilensky director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Mark Guinan officer: Senior Vice President & CFO C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Daniel Stanzione director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094

Quest Diagnostics (Quest Diagnostics) Headlines